Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $2.01 Million - $4.36 Million
-219,800 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$7.25 - $10.99 $587,250 - $890,190
-81,000 Reduced 26.93%
219,800 $2.17 Million
Q1 2021

May 17, 2021

BUY
$4.57 - $11.18 $785,528 - $1.92 Million
171,888 Added 133.34%
300,800 $2.96 Million
Q3 2020

Nov 16, 2020

SELL
$4.32 - $11.7 $3.35 Million - $9.07 Million
-775,567 Reduced 85.75%
128,912 $557,000
Q2 2020

Aug 14, 2020

SELL
$2.94 - $9.1 $5.81 Million - $18 Million
-1,977,557 Reduced 68.62%
904,479 $8.03 Million
Q1 2020

May 15, 2020

SELL
$2.27 - $6.2 $1.54 Million - $4.2 Million
-677,511 Reduced 19.03%
2,882,036 $10.2 Million
Q4 2019

Feb 14, 2020

BUY
$3.46 - $6.93 $741,135 - $1.48 Million
214,201 Added 6.4%
3,559,547 $20.4 Million
Q3 2019

Feb 12, 2020

SELL
$2.69 - $4.85 $3.9 Million - $7.03 Million
-1,450,000 Reduced 30.24%
3,345,346 $12 Million
Q3 2019

Nov 14, 2019

BUY
$2.69 - $4.85 $9.39 Million - $16.9 Million
3,490,000 Added 267.36%
4,795,346 $15.1 Million
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $4.76 Million - $10.3 Million
1,305,346 New
1,305,346 $5.21 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.49B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Bain Capital Public Equity Management Ii, LLC Portfolio

Follow Bain Capital Public Equity Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.